@article{SchoendorfEiseleGoehringetal.2004,
  author    = {Thomas Sch{\"o}ndorf and Lewin Eisele and Uwe-Jochen G{\"o}hring and Markus M. Valter and Mathias Warm and Peter Mallmann and Martina Becker and Roland Fechteler and Maria-Paz Weisshaar and Markus Hoopmann},
  title     = {The V109G Polymorphism of the p27 Gene CDKN1B Indicates a Worse Outcome in Node-Negative Breast Cancer Patients},
  series   = {Tumor Biology},
  volume    = {25},
  number    = {5-6},
  publisher = {Karger},
  address   = {Basel},
  issn      = {1010-4283},
  doi       = {10.1159/000081396},
  url       = {https://nbn-resolving.org/urn:nbn:de:hbz:1044-opus-2219},
  pages     = {306 -- 312},
  year      = {2004},
  abstract  = {Although p27 plays a central role in cell cycle regulation, its role in breast cancer prognosis is controversial. Furthermore, the p27 gene CDKN1B carries a polymorphism with unknown functional relevance. This study was designed to evaluate p27 expression and p27 genotyping with respect to early breast cancer prognosis. 279 patients with infiltrating metastasis-free breast cancer were included in this study. p27 expression was determined in tumor tissue specimens from 261 patients by immunohistochemistry. From 108 patients, the CDKN1B genotype was examined by PCR and subsequent direct sequencing. 55.2\% of the tumors were considered p27 positive. p27 expression did not correlate with any of the established parameters except for nodal involvement but significantly correlated to prolonged disease-free survival. In 35\% of the tumors analyzed, the CDKN1B gene showed a polymorphism at codon 109 (V109G). The V109G polymorphism correlated with greater nodal involvement. In the node-negative subgroup, V109G correlated significantly with a shortened disease-free survival. In conclusion, the determination of the CDKN1B genotype might be a powerful tool for the prognosis of patients with early breast cancer.},
  language  = {en}
}